Johnson & Johnson is the world’s largest consumer health company with perhaps the world’s largest public relations problem. Shareholders would like to know what’s gone wrong with the company and they’ve filed a corruption lawsuit to find out. Ten company board members and several executives have been named including new […]
Category: Defective Drugs
It used to be that the arms industry was the bad boy of all industries. Move over! Big Pharma has now topped the gun trade with a $3 billion fine imposed on GlaxoSmithKline (GSK). Britain’s largest pharmaceutical company, GSK, was just busted for offering lavish incentives to doctors to promote […]
Documents recently posted to the FDA’s website say pharmaceutical company, Amylin, has not been completely forthcoming about its diabetes drug, Byetta, and related drug Bydureon, concerning their potential for cardiovascular complications. The active ingredient is the same in the two drugs which are both used to treat type 2 diabetes. However, Bydureon […]
Two new lawsuits were filed this week against Bayer Corporation by Cal Warriner and Brenda Fulmer on behalf of clients from Oregon. The first lawsuit involves a 37 year old single woman employed in the accounting industry from Portland, Oregon. She ingested both Yaz and Gianvi for less than a year […]
Another DePuy ASR hip implant lawsuit was filed this week against DePuy Orthopaedics and its parent company, Johnson & Johnson. This lawsuit was filed on behalf of a 61 year old woman who lives on a farm near Gainesville, Florida. She had the misfortune of being implanted with not […]
According to an analysis by the Institute for Safe Medication Practices, Pradaxa drug (Dabigatran) topped the list of direct reports to the FDA for serious adverse drug events in 2011. Pradaxa took the lead with 817 direct reports, followed by Coumadin (Warfarin) with 490 direct reports, Levaquin (Levofloxacin) with 393, […]
According to a study published June 11, the users of Actos (pioglitazone) or Avandia (rosiglitazone) may face an increased risk of developing macular edema. Published in the Archives of Internal Medicine, British researchers collected data on more than 100,000 patients with type 2 diabetes who were enrolled in the British […]
By now you’ve heard about the bisphosphonates that are typically prescribed when a woman or man experiences the bone-thinning disease of osteoporosis or osteopenia. They are known by their commercial names of Boniva, Fosamax, Actonel, Reclast and were introduced in the mid-1990s. Introduced in the mid 1990s, a recent New […]
A study published in the New England Journal of Medicine on May 17, 2012, suggests that the popular antibiotic azithromycin may increase the risk of sudden cardiovascular death, especially among patients who are already at risk for cardiovascular disease. Different patient groups were treated with azithromycin (Zithromax), amoxicillin, ciprofloxacin (Cipro), […]
The U.S. Food and Drug Administration (FDA) announced on Wednesday, May 9, that patients taking the osteoporosis drug, Fosamax, or any of the bone-building class of drugs known as bisphosphonates, should be reevaluated every three to five years to determine if it is safe for them to remain on the […]
